Tower Research Capital (TRC)’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.9K | Buy |
274
+128
| +88% | +$6.04K | ﹤0.01% | 3880 |
|
|
2025
Q1 | $5.7K | Buy |
+146
| New | +$5.7K | ﹤0.01% | 4093 |
|
|
2024
Q4 | – | Sell |
-1,672
| Closed | -$84.3K | – | 5885 |
|
|
2024
Q3 | $84.3K | Buy |
1,672
+1,625
| +3,457% | +$81.9K | ﹤0.01% | 2353 |
|
|
2024
Q2 | $2.07K | Sell |
47
-232
| -83% | -$10.2K | ﹤0.01% | 5057 |
|
|
2024
Q1 | $14K | Buy |
279
+214
| +329% | +$10.7K | ﹤0.01% | 3346 |
|
|
2023
Q4 | $3.93K | Sell |
65
-127
| -66% | -$7.67K | ﹤0.01% | 5025 |
|
|
2023
Q3 | $10.9K | Sell |
192
-720
| -79% | -$41K | ﹤0.01% | 4058 |
|
|
2023
Q2 | $46.5K | Buy |
+912
| New | +$46.5K | ﹤0.01% | 2625 |
|
|
2022
Q3 | – | Sell |
-25
| Closed | – | – | 6323 |
|
|
2022
Q2 | $0 | Buy |
+25
| New | – | ﹤0.01% | 6353 |
|
|
2022
Q1 | – | Sell |
-193
| Closed | -$2K | – | 6376 |
|
|
2021
Q4 | $2K | Buy |
193
+76
| +65% | +$788 | ﹤0.01% | 5638 |
|
|
2021
Q3 | $1K | Buy |
117
+100
| +588% | +$855 | ﹤0.01% | 5503 |
|
|
2021
Q2 | $0 | Buy |
+17
| New | – | ﹤0.01% | 5696 |
|
|
2021
Q1 | – | Sell |
-7
| Closed | – | – | 5586 |
|
|
2020
Q4 | $0 | Buy |
+7
| New | – | ﹤0.01% | 5307 |
|